Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
GEMPAX: Gemcitabine and Paclitaxel in Metastatic Pancreatic Cancer
NCT03943667Phase 3Completed
- Sponsor
- Unicancer
- Start
- May 2019
- Primary completion
- Apr 2022
- Modality
- Cytokines & Interferons, Fc-Fusion Proteins
- Countries
- 1
01
Overview
A Phase 3 trial of Paclitaxel Micelles for Injection in pancreatic adenocarcinoma (PDAC), sponsored by Unicancer. Started May 2019; status: completed.
02
Drugs
Paclitaxel Micelles for Injection
03
Conditions
pancreatic adenocarcinoma (PDAC)
Beyond the preview
Go deeper on NCT03943667.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03943667.